Screener
BillionToOne, Inc. BLLN Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$109.4MBeat by $182.3K
EPS$0.15Miss by $0.03
Revenue estimate$109.2M
EPS estimate$0.18
“Our second quarter demonstrated the durability of our model, with our differentiated technology platform, category-defining products, and disciplined execution driving continued growth and profitability. We grew revenue 64% year-over-year to a $438 1 million annualized run-rate while advancing our product roadmap with the launch of Unity Confirm and the upcoming launches of our expanded Fetal Risk Screen and Northstar Origin. We believe we are still in the earliest chapters of what our smNGS platform can achieve, and we remain relentlessly focused on transforming molecular diagnostics and healthcare.”
Next report
Oct 6, 2026 (in 2 months)Revenue estimate$117.4M
EPS estimate$0.23
Valuation & ratios
Segments
By product
Versus estimates
Revenue
Q2 2026$109.4MBeat by $182.3K
Q4 2025$108.4MBeat by $11.3MQ1 2026$108.4MBeat by $11.3MQ3 2025$83.5MBeat by $623.3KDiluted EPS
Q2 2026$0.15Miss by $0.03
Q4 2025$0.34Beat by $0.28Q1 2026$0.34Beat by $0.31Q3 2025$0.10Miss by $0.04FAQ
- When did BillionToOne, Inc. report Q2 2026 earnings?
- BillionToOne, Inc. (BLLN) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were BillionToOne, Inc.'s Q2 2026 revenue and EPS?
- BillionToOne, Inc. reported revenue of $109.4M and eps of $0.15 for Q2 2026.
- Did BillionToOne, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $109.2M by $182.3K. EPS missed the consensus estimate of $0.18 by $0.03.
- Where can I find BillionToOne, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0002070849-26-000048) and the 10-Q periodic report (0002070849-26-000050) directly on SEC EDGAR. The filing index links above go to sec.gov.
